https://www.selleckchem.com/pr....oducts/lenalidomide-
71, 0.69; ICGC 0.8, 0.74; GEO batch 0.61, 0.7, respectively). The hazard ratio (HR) of the low-risk group had a similar significant result (TCGA HR = 0.3723; ICGC HR = 0.2813; GEO batch HR = 0.4999; all P less then 0.001). Furthermore, Log-rank test results in three cohorts showed that the 7-mRNA assay excellently predicted the prognosis and metastasis, especially in TNM stage III subgroups of PDAC. In conclusion, the strong validation of our 7-mRNA signature indicates the promising effectiveness of its clinical applicat
Like
Comment
Share
